It is a business outsourcing private limited company based in Lucknow, Uttar Pradesh, India, established in 2018.
2018 | Lucknow, Uttar Pradesh, India | ActiveInhale Pharmaceuticals Private Limited, a active private limited company, was established on 10 December 2018 in Lucknow, Uttar Pradesh, India. Engaging in business & it consulting within the trade sector, it holds CIN: U24230UP2018PTC111056. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.
Its leadership includes Nisheeth Srivastava (Director), Deepika Srivastava (Director). Past directors included Narendra Srivastava Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 486/70 Station Road Daliganj, Lucknow, Uttar Pradesh, 226020.
U24230UP2018PTC111056
111056
10 December 2018
₹1.00 M
₹0.30 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Inhale Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nisheeth Srivastava | Director | 03 Mar 2020 | Current |
| Deepika Srivastava | Director | 10 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inhale Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 662.87% increase. The company also saw a substantial improvement in profitability, with a 44.41% increase in profit. The company's net worth dipped by a decrease of 3.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Inhale Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Inhale Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inhale Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inhale Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Inhale Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Inhale Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Progress on Nisheeth Srivastava was appointed as a Director was appointed as a Director on 03 Mar 2020 & has been associated with this company since 5 years 9 months . was documented.
Deepika Srivastava was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 7 years 10 days . was recorded as a recent event.
Inhale Pharmaceuticals Private Limited was registered on 10 Dec 2018 with Roc Kanpur & aged 7 years 10 days as per MCA records. was recorded as a recent event.
The CIN of Inhale Pharmaceuticals Private Limited is U24230UP2018PTC111056.
Inhale Pharmaceuticals Private Limited is headquartered at 486/70 Station Road Daliganj, Lucknow, Uttar Pradesh, 226020.
Inhale Pharmaceuticals Private Limited was incorporated on 10 December 2018.
The current directors of Inhale Pharmaceuticals Private Limited are
The primary industry of Inhale Pharmaceuticals Private Limited is Trade.
Inhale Pharmaceuticals Private Limited is unlisted.
The authorized capital of Inhale Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX